Abstract
The tumor microenvironment (TME) is a complex heterogeneous assembly composed of a variety of cell types and physical features. One such feature, hypoxia, is associated with metabolic reprogramming, the epithelial-mesenchymal transition, and therapeutic resistance. Many questions remain regarding the effects of hypoxia on these outcomes; however, only a few experimental methods enable both precise control over oxygen concentration and real-time imaging of cell behavior. Recent efforts with microfluidic platforms offer a promising solution to these limitations. In this review, we discuss conventional methods and tools used to control oxygen concentration for cell studies, and then highlight recent advances in microfluidic-based approaches for controlling oxygen in engineered platforms.
Original language | English (US) |
---|---|
Pages (from-to) | 556-563 |
Number of pages | 8 |
Journal | Trends in Biotechnology |
Volume | 32 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1 2014 |
Keywords
- Hypoxia
- Microfluidics
- Tumor microenvironment
ASJC Scopus subject areas
- Biotechnology
- Bioengineering